APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immunodeficiency Virus (HIV)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Immunodeficiency Virus (HIV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchHuman Immunodeficiency Virus (HIV) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunodeficiency Virus (HIV) Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Human Immunodeficiency Virus (HIV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunodeficiency Virus (HIV) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunodeficiency Virus (HIV) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Human Immunodeficiency Virus (HIV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Immunodeficiency Virus (HIV) include Merck & Co., Inc., Mylan, AbbVie, ViiV Healthcare, Genentech, Inc., Genentech, Inc., Cipla, Inc., Bristol-Myers Squibb Company and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Human Immunodeficiency Virus (HIV) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Immunodeficiency Virus (HIV) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Immunodeficiency Virus (HIV) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Human Immunodeficiency Virus (HIV) market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Immunodeficiency Virus (HIV) Segment by Company

Merck & Co., Inc.

Mylan

AbbVie

ViiV Healthcare

Genentech, Inc.

Genentech, Inc.

Cipla, Inc.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH

Human Immunodeficiency Virus (HIV) Segment by Type

Protease Inhibitors

NNRTIs

Coreceptor Antagonists

NRTIs

Entry and Fusion Inhibitors

Integrase Inhibitors

Human Immunodeficiency Virus (HIV) Segment by Application

Clinics

Hospitals

Labs

Human Immunodeficiency Virus (HIV) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunodeficiency Virus (HIV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunodeficiency Virus (HIV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunodeficiency Virus (HIV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Human Immunodeficiency Virus (HIV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Immunodeficiency Virus (HIV) industry.

Chapter 3: Detailed analysis of Human Immunodeficiency Virus (HIV) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Immunodeficiency Virus (HIV)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Protease Inhibitors Table 3. Key Players of NNRTIs Table 4. Key Players of Coreceptor Antagonists Table 3. Key Players of NRTIs Table 4. Key Players of Entry and Fusion Inhibitors Table 5. Key Players of Integrase Inhibitors Table 6. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Clinics Table 8. Key Players of Hospitals Table 9. Key Players of Labs Table 10. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Human Immunodeficiency Virus (HIV) Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2021-2026) Table 13. Global Human Immunodeficiency Virus (HIV) Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2027-2032) Table 15. Human Immunodeficiency Virus (HIV) Industry Trends Table 16. Human Immunodeficiency Virus (HIV) Industry Drivers Table 17. Human Immunodeficiency Virus (HIV) Industry Opportunities and Challenges Table 18. Human Immunodeficiency Virus (HIV) Industry Restraints Table 19. Global Human Immunodeficiency Virus (HIV) Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Company (2021-2026) Table 21. Global Human Immunodeficiency Virus (HIV) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Human Immunodeficiency Virus (HIV) Key Company Head Office and Area Served Table 23. Global Human Immunodeficiency Virus (HIV) Company, Product Type & Application Table 24. Global Human Immunodeficiency Virus (HIV) Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Human Immunodeficiency Virus (HIV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Human Immunodeficiency Virus (HIV) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2021-2026) Table 31. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2027-2032) Table 32. Global Human Immunodeficiency Virus (HIV) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2021-2026) Table 36. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2027-2032) Table 37. Merck & Co., Inc. Company Information Table 38. Merck & Co., Inc. Business Overview Table 39. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 41. Merck & Co., Inc. Recent Development Table 42. Mylan Company Information Table 43. Mylan Business Overview Table 44. Mylan Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Mylan Human Immunodeficiency Virus (HIV) Product Portfolio Table 46. Mylan Recent Development Table 47. AbbVie Company Information Table 48. AbbVie Business Overview Table 49. AbbVie Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. AbbVie Human Immunodeficiency Virus (HIV) Product Portfolio Table 51. AbbVie Recent Development Table 52. ViiV Healthcare Company Information Table 53. ViiV Healthcare Business Overview Table 54. ViiV Healthcare Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. ViiV Healthcare Human Immunodeficiency Virus (HIV) Product Portfolio Table 56. ViiV Healthcare Recent Development Table 57. Genentech, Inc. Company Information Table 58. Genentech, Inc. Business Overview Table 59. Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 61. Genentech, Inc. Recent Development Table 62. Genentech, Inc. Company Information Table 63. Genentech, Inc. Business Overview Table 64. Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 66. Genentech, Inc. Recent Development Table 67. Cipla, Inc. Company Information Table 68. Cipla, Inc. Business Overview Table 69. Cipla, Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cipla, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 71. Cipla, Inc. Recent Development Table 72. Bristol-Myers Squibb Company Company Information Table 73. Bristol-Myers Squibb Company Business Overview Table 74. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Product Portfolio Table 76. Bristol-Myers Squibb Company Recent Development Table 77. Boehringer Ingelheim GmbH Company Information Table 78. Boehringer Ingelheim GmbH Business Overview Table 79. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio Table 81. Boehringer Ingelheim GmbH Recent Development Table 82. Boehringer Ingelheim GmbH Company Information Table 83. Boehringer Ingelheim GmbH Business Overview Table 84. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio Table 86. Boehringer Ingelheim GmbH Recent Development Table 87. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 88. North America Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032) & (US$ Million) Table 89. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 90. North America Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032) & (US$ Million) Table 91. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) Table 93. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032) Table 94. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 95. Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032) & (US$ Million) Table 96. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 97. Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032) & (US$ Million) Table 98. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) Table 100. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032) Table 101. China Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 102. China Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032) & (US$ Million) Table 103. China Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 104. China Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 106. Asia Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032) & (US$ Million) Table 107. Asia Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 108. Asia Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) Table 111. Asia Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032) Table 112. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) Table 118. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Human Immunodeficiency Virus (HIV) Product Image Figure 2. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Human Immunodeficiency Virus (HIV) Market Share by Type: 2025 VS 2032 Figure 4. Protease Inhibitors Image Figure 5. NNRTIs Image Figure 6. Coreceptor Antagonists Image Figure 7. NRTIs Image Figure 8. Entry and Fusion Inhibitors Image Figure 9. Integrase Inhibitors Image Figure 10. Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Human Immunodeficiency Virus (HIV) Market Share by Application: 2025 VS 2032 Figure 12. Clinics Image Figure 13. Hospitals Image Figure 14. Labs Image Figure 15. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 17. Global Human Immunodeficiency Virus (HIV) Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Human Immunodeficiency Virus (HIV) Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Human Immunodeficiency Virus (HIV) Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Type (2021-2032) Figure 24. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Application (2021-2032) Figure 26. North America Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 27. North America Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032) Figure 28. North America Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032) Figure 29. North America Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 30. United States Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 31. Canada Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 33. Europe Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 34. Europe Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032) Figure 35. Europe Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032) Figure 36. Europe Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 37. Germany Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 38. France Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 40. Italy Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 41. Russia Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 43. China Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 44. China Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032) Figure 45. China Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032) Figure 46. Asia Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 47. Asia Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032) Figure 48. Asia Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032) Figure 49. Asia Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 50. Japan Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 54. India Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 55. Australia Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 60. Brazil Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 65. UAE Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 67. Chile Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Protease Inhibitors
  • NNRTIs
  • Coreceptor Antagonists
  • NRTIs
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
Applications
  • Clinics
  • Hospitals
  • Labs
Companies covered
  • Merck & Co., Inc.
  • Mylan
  • AbbVie
  • ViiV Healthcare
  • Genentech, Inc.
  • Genentech, Inc.
  • Cipla, Inc.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Boehringer Ingelheim GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Protease Inhibitors
  5. 1.2.3 NNRTIs
  6. 1.2.4 Coreceptor Antagonists
  7. 1.2.5 NRTIs
  8. 1.2.6 Entry and Fusion Inhibitors
  9. 1.2.7 Integrase Inhibitors
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Human Immunodeficiency Virus (HIV) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Clinics
  13. 1.3.3 Hospitals
  14. 1.3.4 Labs
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Human Immunodeficiency Virus (HIV) Growth Trends by Region
  17. 1.5.1 Global Human Immunodeficiency Virus (HIV) Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Human Immunodeficiency Virus (HIV) Market Size by Region (2021-2026)
  19. 1.5.3 Human Immunodeficiency Virus (HIV) Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Human Immunodeficiency Virus (HIV) Market Dynamics
  1. 2.1 Human Immunodeficiency Virus (HIV) Industry Trends
  2. 2.2 Human Immunodeficiency Virus (HIV) Industry Drivers
  3. 2.3 Human Immunodeficiency Virus (HIV) Industry Opportunities and Challenges
  4. 2.4 Human Immunodeficiency Virus (HIV) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Human Immunodeficiency Virus (HIV) Revenue by Company (2021-2026)
  2. 3.2 Global Human Immunodeficiency Virus (HIV) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Human Immunodeficiency Virus (HIV) Key Company Head office and Area Served
  4. 3.4 Global Human Immunodeficiency Virus (HIV) Company, Product Type & Application
  5. 3.5 Global Human Immunodeficiency Virus (HIV) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Human Immunodeficiency Virus (HIV) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Human Immunodeficiency Virus (HIV) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Human Immunodeficiency Virus (HIV) Tier 1, Tier 2, and Tier 3
4 Human Immunodeficiency Virus (HIV) Market by Type
  1. 4.1 Global Human Immunodeficiency Virus (HIV) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2032)
  3. 4.3 Global Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2032)
5 Human Immunodeficiency Virus (HIV) Market by Application
  1. 5.1 Global Human Immunodeficiency Virus (HIV) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2032)
  3. 5.3 Global Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck & Co., Inc.
  2. 6.1.1 Merck & Co., Inc. Company Information
  3. 6.1.2 Merck & Co., Inc. Business Overview
  4. 6.1.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  6. 6.1.5 Merck & Co., Inc. Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Mylan Human Immunodeficiency Virus (HIV) Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 AbbVie Human Immunodeficiency Virus (HIV) Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 ViiV Healthcare
  20. 6.4.1 ViiV Healthcare Company Information
  21. 6.4.2 ViiV Healthcare Business Overview
  22. 6.4.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ViiV Healthcare Human Immunodeficiency Virus (HIV) Product Portfolio
  24. 6.4.5 ViiV Healthcare Recent Developments
  25. 6.5 Genentech, Inc.
  26. 6.5.1 Genentech, Inc. Company Information
  27. 6.5.2 Genentech, Inc. Business Overview
  28. 6.5.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  30. 6.5.5 Genentech, Inc. Recent Developments
  31. 6.6 Genentech, Inc.
  32. 6.6.1 Genentech, Inc. Company Information
  33. 6.6.2 Genentech, Inc. Business Overview
  34. 6.6.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  36. 6.6.5 Genentech, Inc. Recent Developments
  37. 6.7 Cipla, Inc.
  38. 6.7.1 Cipla, Inc. Company Information
  39. 6.7.2 Cipla, Inc. Business Overview
  40. 6.7.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Cipla, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  42. 6.7.5 Cipla, Inc. Recent Developments
  43. 6.8 Bristol-Myers Squibb Company
  44. 6.8.1 Bristol-Myers Squibb Company Company Information
  45. 6.8.2 Bristol-Myers Squibb Company Business Overview
  46. 6.8.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Company Recent Developments
  49. 6.9 Boehringer Ingelheim GmbH
  50. 6.9.1 Boehringer Ingelheim GmbH Company Information
  51. 6.9.2 Boehringer Ingelheim GmbH Business Overview
  52. 6.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio
  54. 6.9.5 Boehringer Ingelheim GmbH Recent Developments
  55. 6.10 Boehringer Ingelheim GmbH
  56. 6.10.1 Boehringer Ingelheim GmbH Company Information
  57. 6.10.2 Boehringer Ingelheim GmbH Business Overview
  58. 6.10.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio
  60. 6.10.5 Boehringer Ingelheim GmbH Recent Developments
7 North America
  1. 7.1 North America Human Immunodeficiency Virus (HIV) Market Size (2021-2032)
  2. 7.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type
  3. 7.2.1 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026)
  4. 7.2.2 North America Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032)
  5. 7.2.3 North America Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032)
  6. 7.3 North America Human Immunodeficiency Virus (HIV) Market Size by Application
  7. 7.3.1 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026)
  8. 7.3.2 North America Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032)
  9. 7.3.3 North America Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032)
  10. 7.4 North America Human Immunodeficiency Virus (HIV) Market Size by Country
  11. 7.4.1 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  13. 7.4.3 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032)
  14. 7.4.4 North America Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Human Immunodeficiency Virus (HIV) Market Size (2021-2032)
  2. 8.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type
  3. 8.2.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032)
  6. 8.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Application
  7. 8.3.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032)
  10. 8.4 Europe Human Immunodeficiency Virus (HIV) Market Size by Country
  11. 8.4.1 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Human Immunodeficiency Virus (HIV) Market Size (2021-2032)
  2. 9.2 China Human Immunodeficiency Virus (HIV) Market Size by Type
  3. 9.2.1 China Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026)
  4. 9.2.2 China Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032)
  5. 9.2.3 China Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032)
  6. 9.3 China Human Immunodeficiency Virus (HIV) Market Size by Application
  7. 9.3.1 China Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026)
  8. 9.3.2 China Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032)
  9. 9.3.3 China Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Human Immunodeficiency Virus (HIV) Market Size (2021-2032)
  2. 10.2 Asia Human Immunodeficiency Virus (HIV) Market Size by Type
  3. 10.2.1 Asia Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032)
  6. 10.3 Asia Human Immunodeficiency Virus (HIV) Market Size by Application
  7. 10.3.1 Asia Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032)
  10. 10.4 Asia Human Immunodeficiency Virus (HIV) Market Size by Country
  11. 10.4.1 Asia Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst